LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1401 | 2732 | 4213 | 0.6484 | 0.5225 |
| SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1401 | 2807 | 4545 | 0.6175 | 0.5055 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 1401 | 1887 | 3978 | 0.4743 | 0.2185 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 1401 | 1771 | 4213 | 0.4203 | 0.1588 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 1401 | 2029 | 4545 | 0.4463 | 0.2435 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1401 | 1289 | 3978 | 0.3240 | -0.0541 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1401 | 1162 | 4213 | 0.2758 | -0.1113 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1401 | 1385 | 4545 | 0.3047 | -0.0070 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 1401 | 999 | 3978 | 0.2511 | -0.2014 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 1401 | 978 | 4213 | 0.2321 | -0.2028 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 1401 | 1182 | 4545 | 0.2600 | -0.0955 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 1 | H01 | 72 | hr | 1401 | 986 | 3978 | 0.2478 | -0.2083 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 2 | H01 | 72 | hr | 1401 | 922 | 4213 | 0.2188 | -0.2318 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 3 | H01 | 72 | hr | 1401 | 1027 | 4545 | 0.2259 | -0.1674 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1401 | 4488 | 3978 | 1.1280 | 1.1667 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 1401 | 4710 | 4213 | 1.1179 | 1.1454 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 1401 | 4787 | 4545 | 1.0530 | 1.0618 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 1401 | 5210 | 3978 | 1.3095 | 1.3924 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 1401 | 4452 | 4213 | 1.0567 | 1.0706 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 1401 | 4803 | 4545 | 1.0565 | 1.0659 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 1401 | 5312 | 3978 | 1.3352 | 1.4234 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 1401 | 4381 | 4213 | 1.0398 | 1.0498 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 3 | G10 | 72 | hr | 1401 | 4367 | 4545 | 0.9606 | 0.9533 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 1401 | 4963 | 3978 | 1.2474 | 1.3164 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 2 | G09 | 72 | hr | 1401 | 5030 | 4213 | 1.1938 | 1.2361 |